← Back to Search

MyPADMGT for Peripheral Arterial Disease (Final_PADHSS Trial)

N/A
Waitlist Available
Led By Michael Stacey, MD
Research Sponsored by McMaster University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Out-patients with Peripheral Arterial Disease (Ankle Brachial Index < 0.90)
Attending the Hamilton General Hospital Outpatient Vascular Clinic
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights

Final_PADHSS Trial Summary

This trial will test an online program to help people with peripheral arterial disease and high blood pressure to better self-manage their condition.

Eligible Conditions
  • Peripheral Arterial Disease

Final_PADHSS Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Final_PADHSS Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
EQ-5D-5L Quality of Life Visual Result
Systolic Blood Pressure
Secondary outcome measures
Ankle Brachial Index
Body Weight
Smoking Cessation
+1 more

Final_PADHSS Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: MyPADMGT + NudgingExperimental Treatment1 Intervention
Online access to system, with ability to record and study progress with social interaction, diet, physical activity, smoking cessation, blood glucose, blood pressure and weight. Also access to educational content, journal recording, communication to others, setting target levels, contact support as needed. In addition, nudging support available to help patients make better choices and decisions.
Group II: MyPADMGTExperimental Treatment1 Intervention
Online access to system, with ability to record and study progress with social interaction, diet, physical activity, smoking cessation, blood glucose, blood pressure and weight. Also access to educational content, journal recording, communication to others, setting target levels, contact support as needed.
Group III: ControlActive Control1 Intervention
Usual care

Find a Location

Who is running the clinical trial?

McMaster UniversityLead Sponsor
877 Previous Clinical Trials
2,595,934 Total Patients Enrolled
2 Trials studying Peripheral Arterial Disease
200 Patients Enrolled for Peripheral Arterial Disease
Michael Stacey, MDPrincipal InvestigatorMcMaster University

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any available spaces for participants in this research experiment?

"Affirmative. The clinical trial's page hosted on clinicaltrials.gov displays that recruitment is currently active; the study was posted on February 24th 2021 and last modified March 8th 2021, with it needing to enlist 210 participants from a single medical centre."

Answered by AI

What objectives has this experiment been designed to accomplish?

"This trial has a one-year timeline and seeks to evaluate Quality of Life Visual Result using the EQ-5D-5L scale. Additionally, participants will have their Body Weight (BMI relative to healthy range), Social Isolation (Hawthorne Friendship Scale Questionnaire scores) and Smoking cessation tracked, with higher outcome scores indicating superior results."

Answered by AI

What is the cap on participants for this research endeavor?

"Affirmative. The clinicaltrials.gov portal confirms that this investigation, which was first made available on February 24th 2021 is still actively recruiting for candidates. A total of 210 people need to be recruited from 1 site in particular."

Answered by AI
~31 spots leftby Mar 2025